Cargando…

Erb-B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53-responsive microRNA-3184-5p in cervical cancer cells

The oncogenic role of Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2) has been identified in several types of cancer, but less is known on its function and mechanism of action in cervical cancer cells. The present study employed a multipronged approach to investigate the role of ERBB2 in cervical cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hongli, Li, Yuzhi, Zhang, Jing, Wu, Nan, Liu, Fei, Wang, Lihua, Zhang, Yuan, Liu, Jing, Zhang, Xuan, Guo, Suyang, Wang, Hongtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709819/ https://www.ncbi.nlm.nih.gov/pubmed/33416166 http://dx.doi.org/10.3892/or.2020.7862

Ejemplares similares

miR‐3184‐3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2‐like macrophage polarization
por: Xu, Hao, et al.
Publicado: (2022)

3184 Development of a Leadership Assessment Scale in Translational Science
por: Vaughan, Roger, et al.
Publicado: (2019)

LncRNA FOXP4‐AS promotes the progression of non‐small cell lung cancer by regulating the miR‐3184‐5p/EIF5A axis
por: Li, Dingbiao, et al.
Publicado: (2022)

Circular RNA circEMB promotes osteosarcoma progression and metastasis by sponging miR-3184-5p and regulating EGFR expression
por: Tan, Jianye, et al.
Publicado: (2023)

p53 and erbB-2 Are Not Associated in Matched Cases of Primary and Metastatic Ovarian Carcinomas
por: Rodríguez-Burford, Cristina, et al.
Publicado: (2003)

EGFR/erb-1, HER2/erb-2, CK7, LP34, Ki67 and p53 expression in preneoplastic lesions of bronchial epithelium
por: Carvalho, Lina, et al.
Publicado: (2010)

Mutational Screening in Tyrosine-Kinase Domain of erbB1 And erbB2 Genes
por: ALONSO, Juan Manuel Fernández
Publicado: (2005)

Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.
por: Mehta, R. R., et al.
Publicado: (1995)

ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells
por: Li, Dun, et al.
Publicado: (2016)

LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4
por: Wu, Xingcheng, et al.
Publicado: (2019)

Receptor Tyrosine Kinase ErbB2 Translocates into Mitochondria and Regulates Cellular Metabolism
por: Ding, Yan, et al.
Publicado: (2012)

Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells
por: Kong, Lu, et al.
Publicado: (2015)

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
por: Archer, S. G., et al.
Publicado: (1995)

Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells
por: Chen, Haibo, et al.
Publicado: (2017)

Insulin Receptor Tyrosine Kinase Substrate Enhances Low Levels of MDM2-Mediated p53 Ubiquitination
por: Wang, Ke-Sheng, et al.
Publicado: (2011)

p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic Grade
por: Tsuda, Hitoshi, et al.
Publicado: (1993)

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction
por: Zhao, Jing, et al.
Publicado: (2021)

N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis
por: Liu, Na, et al.
Publicado: (2008)

Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582
por: Chaube, Amita, et al.
Publicado: (2006)

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.
por: Niskanen, E., et al.
Publicado: (1997)

Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors
por: Gee, Julia MW
Publicado: (2002)

Irreversible tyrosine kinase inhibitors induce the endocytosis and downregulation of ErbB2
por: Ghosh, Chinmoy, et al.
Publicado: (2023)

NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
por: Liu, Xiaofeng, et al.
Publicado: (2016)

The effect of isochromosome 17q presence, proliferative and apoptotic indices, expression of c-erbB-2, bcl-2 and p53 proteins on the prognosis of medulloblastoma.
por: Nam, D. H., et al.
Publicado: (2000)

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016)

Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
por: Zhang, Jinrui, et al.
Publicado: (2019)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Spleen Tyrosine Kinase Inhibition Modulates p53 Activity
por: Althubiti, Mohammad
Publicado: (2017)

MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling
por: Zhang, Cen, et al.
Publicado: (2014)

Expression of Bcl-2 and p53 at the fetal-maternal interface of rhesus monkey
por: Wei, Peng, et al.
Publicado: (2005)

Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis
por: Liu, Shijie, et al.
Publicado: (2016)

The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003)

The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
por: Zhang, Jinrui, et al.
Publicado: (2020)

The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
por: Kim, J. P., et al.
Publicado: (1994)

Detection and pathological value of papillomavirus DNA and p16(INK4A) and p53 protein expression in cervical intraepithelial neoplasia
por: WU, JINGBO, et al.
Publicado: (2014)

Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
por: Wei, Hudie, et al.
Publicado: (2023)

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction
por: Clegg, Hilary V., et al.
Publicado: (2012)

Editorial: Role of p53 in cell metabolism, ferroptosis, and stemness
por: Lu, Jordan, et al.
Publicado: (2023)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
por: Stern, David F
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_ndj3g0le82tq9579deqcqslosi